PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

ClinicalTrials.gov ID: NCT05313165

Public ClinicalTrials.gov record NCT05313165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial

Study identification

NCT ID: NCT05313165
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: LimFlow, Inc.; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

LimFlow Stent Graft System Device

Device

Eligibility (public fields only)

Age range: 18 Years to 95 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 21, 2022
Primary completion: Apr 30, 2027
Completion: Apr 30, 2027
Last update posted: Apr 15, 2026

2022 – 2027

United States locations

U.S. sites: 30
U.S. states: 17
U.S. cities: 25

Facility	City	State	ZIP	Site status
University of California, San Diego Health	La Jolla	California	92093	Withdrawn
Stanford University School of Medicine	Palo Alto	California	94304	Completed
UCSF	San Francisco	California	94143	Completed
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Torrance	California	90502	Completed
Yale University	New Haven	Connecticut	06519	Completed
The Cardiac and Vascular Institute	Gainesville	Florida	32605	Recruiting
University of Florida	Gainesville	Florida	32608	Completed
Tallahassee Research Institute	Tallahassee	Florida	32308	Withdrawn
Rush University Medical Center	Chicago	Illinois	60612	Completed
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Boston Medical Center	Boston	Massachusetts	02118	Withdrawn
UMass Chan Medical School	Worcester	Massachusetts	01655	Completed
Washington University / Barnes Jewish	St Louis	Missouri	63110	Withdrawn
Dartmouth-Hitchcock Medical Center	Lebanon	New Hampshire	03766	Recruiting
Vascular Institute of Atlantic Medical Imaging	Pomona	New Jersey	08240	Completed
Holy Name Medical Center	Teaneck	New Jersey	07666	Completed
Presbyterian Healthcare	Albuquerque	New Mexico	87113	Completed
Northwell Health Long Island Jewish Medical Center	Lake Success	New York	11042	Recruiting
NYU Langone Health	New York	New York	10016	Completed
Mount Sinai	New York	New York	10029	Completed
Cornell University	New York	New York	10065	Completed
Atrium Health	Charlotte	North Carolina	28204	Completed
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
Penn State Health	Hershey	Pennsylvania	17033	Completed
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37212	Recruiting
UT Southwestern Medical Center	Dallas	Texas	75390	Completed
Sentara Norfolk General Hospital	Norfolk	Virginia	23507	Recruiting
Ascension Columbia St. Mary's Hospital	Milwaukee	Wisconsin	53211	Withdrawn
The Medical College of Wisconsin	Milwaukee	Wisconsin	53226	Withdrawn

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05313165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 15, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05313165 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →